In June 2022, the members of the European Alliance for Responsible R&D and Affordable Medicines gathered successful Rome to analyse the existent nationalist wellness country and sermon imaginable solutions to the astir salient challenges. In airy of nationalist wellness outbreaks successful the European Union (EU), specified arsenic COVID-19 and Monkeypox, the urgent planetary request for aesculapian tools specified arsenic vaccines, and the revision of the EU Pharmaceutical Strategy, the Alliance highlighted the request to guarantee that radical person entree to medicines they request and telephone connected for an R&D strategy that is driven by wellness needs and delivers medicines and different wellness technologies which are safe, effective, universally accessible and affordable.
Within this context, and with the sole purpose of fostering nationalist wellness from a patient-centred perspective, the Joint Rome Declaration calls global, EU, and nationalist policymakers to:
- Secure available, affordable and accessible medicines, including by ensuring that the revision of the EU pharmaceutical authorities is transparent, addresses capable diligent access, and prioritizes nationalist wellness and patients’ needs;
- Use incentives for caller antibiotics that delink the outgo of concern successful R&D from the prices and measurement of income portion adopting an end-to-end attack and avoiding the instauration of caller market-based inducement (such arsenic transferable exclusivity vouchers);
- Set higher standards for patentability astatine the European Patent Office to guarantee that patents are granted to genuinely caller and genuinely innovative medicines;
- Remove legislative and regulatory obstacles to the usage of TRIPS flexibilities specified arsenic compulsory licenses oregon parallel imports from EU ineligible frameworks;
- Promote transparency of R&D and different costs arsenic good arsenic nett prices of medicines, arsenic good arsenic rack nationalist and backstage backing for pharmaceutical R&D crossed the afloat worth concatenation to reconstruct equilibrium into the pharmaceutical sector;
- Ensure transparency and accountability of governmental decisions astatine cardinal institutions specified arsenic the European Medicines Authority (EMA) and the recently formed European Health Emergency Preparedness and Response (HERA);
- Commit nationalist funds to enactment a needs-driven attack to pharmaceutical R&D and code unmet needs and present efficaciously enforceable conditions to nationalist R&D backing to clasp the pharmaceutical manufacture accountable;
- Prevent medicine shortages and trim their interaction connected patients and healthcare providers by strengthening monitoring of cardinal starting materials and precedence APIs arsenic good arsenic finished pharmaceutical products;
- Ensure the co-creation of European pharmaceutical policies by facilitating the meaningful engagement of patients, consumers, and healthcare professionals and civilian society;
- Strengthen existing authorities connected the quality rights duties of pharmaceutical companies successful narration to entree to medicines successful the EU.
English (US)